Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | Bl, ELISA, IF, IHC |
| Reactivities | Human |
Antibodies
SARS-CoV-2 monoclonal antibody (CB6 biosimilar)
| Applications | ELISA, FC |
| Reactivities | SARS-CoV-2 |
SARS-CoV monoclonal antibody (CR3022 biosimilar)
| Applications | ELISA, FC |
| Reactivities | SARS-CoV-2 |
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
CS1 monoclonal antibody (elotuzumab biosimilar)
| Applications | ELISA, FC |
| Reactivities | Human |
IL6 monoclonal antibody (siltuximab biosimilar)
| Applications | ELISA, FC |
| Reactivities | Human |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
CD138 monoclonal antibody (indatuximab ravtansine biosimilar)
| Applications | FC |
| Reactivities | Human |
CD33 monoclonal antibody (gemtuzumab ozogamicin biosimilar)
| Applications | FC |
| Reactivities | Human |
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
| Applications | ELISA |
| Reactivities | Human |
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
| Applications | ELISA |
| Reactivities | Human |
Recombinant Anti-IL-6 receptor (Clone rhPM-1 (Tocilizumab))
| Applications | ELISA |
| Reactivities | Human |
